Literature DB >> 9282846

Arteriovenous malformation model for training and research.

C W Kerber1, S T Hecht, K Knox.   

Abstract

PURPOSE: To develop an arteriovenous malformation (AVM) model for teaching embolization techniques and for researching and developing new interventional devices.
METHODS: Open pore cellulose sponges 2 to 5 cm in diameter were coated with a watertight elastomer. One to three afferent tubes (arteries) and one large efferent tube (vein) allowed insertion of the model into a circuit of pulsatile, flowing, non-Newtonian fluid. Using fluoroscopy and angiographic imaging, five neuroradiologists practiced occluding the AVM nidus with a variety of techniques and cyanoacrylate mixtures.
RESULTS: The model appeared and behaved like a human brain AVM. Attempts to teach liquid adhesive techniques were successful, and though they were stressful for the trainee, failure had none of the disastrous sequelae that attend training with human subjects.
CONCLUSION: The AVM training and research model is of value in introducing physicians to the techniques needed for endovascular cyanoacrylate therapy: it allows users to develop skills at their own rates, and permits safe "failure-mode" learning.

Entities:  

Mesh:

Year:  1997        PMID: 9282846      PMCID: PMC8338034     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  3 in total

1.  In-Vitro Simulation of NBCA Embolization for Arteriovenous Malformation.

Authors:  S Inagawa; H Isoda; H Kougo; S Isogais; H Sakahara
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

2.  Arteriovenous malformation model in Swine: a natural history study: preliminary results.

Authors:  J Klisch; L Yin; F Requejo; M Schumacher
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

3.  A Computational Framework for Pre-Interventional Planning of Peripheral Arteriovenous Malformations.

Authors:  Gaia Franzetti; Mirko Bonfanti; Cyrus Tanade; Chung Sim Lim; Janice Tsui; George Hamilton; Vanessa Díaz-Zuccarini; Stavroula Balabani
Journal:  Cardiovasc Eng Technol       Date:  2021-10-05       Impact factor: 2.305

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.